Cellbricks Therapeutics vs CTIBIOTECH USA
Cellbricks Therapeutics vs CTIBIOTECH USA, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellbricks Therapeutics is on 53/100 and CTIBIOTECH USA on 46/100.
Where each one leads
Cellbricks Therapeutics
- our overall score: 53/100 against 46/100
- funding raised: $7.0M against $4.3M
CTIBIOTECH USA
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cellbricks Therapeutics | CTIBIOTECH USA |
|---|---|---|
| What it is | Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing. | North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue. |
| Category | Biotechnology, Medical Devices, Regenerative Medicine, 3D Printing | Biotechnology, Healthcare, 3D Printing, Regenerative Medicine |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | Not published | 2024 |
| Headquarters | Berlin, Germany | Philadelphia, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellbricks Therapeutics | CTIBIOTECH USA |
|---|---|---|
| Employees | Not published | 22 |
| Total funding | $7.0M | $4.3M |
| Latest round | Seed | Undisclosed |
| LinkedIn followers | Not published | 7,543 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellbricks Therapeutics | CTIBIOTECH USA |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 46/100 |
| Traction | 35/100 | 47/100 |
| Team | 70/100 | Not published |
| Search visibility | 13/100 | 31/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (50/100) |
| Domain ratingLink authority, 0-100 | Not published | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellbricks Therapeutics | CTIBIOTECH USA |
|---|---|---|
| Frameworks | Not detected | Astro |
Cellbricks Therapeutics vs CTIBIOTECH USA: common questions
Which is better, Cellbricks Therapeutics or CTIBIOTECH USA?
On our 0-100 score Cellbricks Therapeutics rates higher (53/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do Cellbricks Therapeutics and CTIBIOTECH USA compare on the numbers?
Cellbricks Therapeutics leads on our overall score (53/100 against 46/100), funding raised ($7.0M against $4.3M).
Read the full Cellbricks Therapeutics review and pricing or the CTIBIOTECH USA review and pricing. You can also browse other Cellbricks Therapeutics alternatives we track.